Cargando…
Scoping review of disease-modifying effect of drugs in experimental epilepsy
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and sociologic concerns for affected patients and their families. To date, treatment of epilepsy is primarily symptomatic management because few effective preventative or disease-modifying interventions...
Autores principales: | Ots, Heather D., Anderson, Taylor, Sherrerd-Smith, William, DelBianco, John, Rasic, Gordana, Chuprin, Anthony, Toor, Zeeshan, Fitch, Elizabeth, Ahuja, Kripa, Reid, Faith, Musto, Alberto E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997527/ https://www.ncbi.nlm.nih.gov/pubmed/36908628 http://dx.doi.org/10.3389/fneur.2023.1097473 |
Ejemplares similares
-
Use of non-medical cannabis in epilepsy: A scoping review
por: Li, Jimmy, et al.
Publicado: (2023) -
The Epilepsy Risk Awareness (ERA) Scale: A New Era for Holistic Risk Assessment in Epilepsy
por: Ison, Rachel, et al.
Publicado: (2020) -
Circadian Rhythms and Epilepsy: A Suitable Case for Absence Epilepsy
por: Smyk, Magdalena K., et al.
Publicado: (2020) -
Metabolic Control of Epilepsy: A Promising Therapeutic Target for Epilepsy
por: Fei, Yanqing, et al.
Publicado: (2020) -
A Rare Case of Insular Epilepsy: Not To Be Missed in Refractory Epilepsy Patients
por: Kurukumbi, Mohan, et al.
Publicado: (2019)